Harmonization: Developing consistent guidelines for applying mode of action and dosimetry information to cancer and noncancer risk assessment

Human and Ecological Risk Assessment (HERA)

Volumn 4, Issue 1, 1998, Pages 75-115

  Barton, Hugh A ^a,c   Andersen, Melvin E ^a,c   Clewell III, Harvey J ^b  

^a ICF Kaiser International   (United States)

^b KS Crump Group   (United States)

^c KS Crump Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0346453784     PISSN: 10807039     EISSN: None     Source Type: Journal    
DOI: 10.1080/10807039891284226     Document Type: Article

References (73)

1. ACGIH (American Council of Governmental Industrial Hygienists). A. C. o. G. I. H. 1996. Threshold Limit Values (TLVs™) for Chemical Substances and Physical Agents and Biological Exposure Indices (BEIs™). Cincinnati, OH.
2. Albert, R. E., Train, R. E., and Anderson, E. 1977. Rationale Developed by the Environmental Protection Agency for the Assessment of Carcinogenic Risks. J. Natl. Cancer Inst. 58(5), 1537-1541.
3. Amdur, M. O. 1989. Health Effects of Air Pollutants: Sulfuric Acid, the Old and the New. Environ. Health Perspect. 81, 109-114.
4. Andersen, M.E. 1987. Tissue Dosimetry in Risk Assessment, or What's the Problem Here Anyway? In: Drinking Water and Health. Volume 8: Pharmacokinetics in Risk Assessment. Washington, DC, National Academy Press.
5. Andersen, M. E., Clewell, H. J., III, Gargas, M. L., Smith, F. A., and Reitz, R. H. 1987. Physiologically Based Pharmacokinetics and the Risk Assessment Process for Methylene Chloride. Toxicol. Appl. Pharmacol. 87, 185-205.
6. Andersen, M.E., Clewell, J. H., III, Gearhart J., Allen, B. C., and Barton, H. A. 1997. A Pharmacodynamic Model of the Rat Estrus Cycle in Relation to Endocrine Disruptors. J. Toxicol. Environ. Health 52, 189-209.
7. Ashby, J., Doerrer, N. G., Flamm, F. G., Harris, J. E., Hughes, D. H., Johannsen, F. R., Lewis, S. C., Krivanek, N. D., McCarthy, J. F., Moolenaar, R. J., Raabe, G. K., Reynolds, R. C., Smith, J. M., Stevens, J. T., Teta, M. J., Wilson,J. D. 1990. A Scheme for Classifying Carcinogens. Regul. Toxicol. Pharmacol. 12, 270-295.
8. ATSDR. (Agency for Toxic Substances and Disease Registry). 1997. ATSDR's Toxicological Profiles on CD-ROM., CRC Press Inc.
9. Barnes, D. G. and Dourson, M. 1988. Reference Dose (RfD): Description and Use in Health Risk Assessments. Regul. Toxicol. Pharmacol. 8, 471-486.
10. Barton, H. A. and Das, S. 1996. Alternatives for a Risk Assessment on Chronic Noncancer Effects from Oral Exposure to Trichloroethylene. Regul. Toxicol. Pharmacol. 24, 269-285.
11. Borghoff, S. J., Gargas, M. J., Andersen, M. E., and Conolly, R. B. 1995. Development of a Mechanism-Based Dosimetry Model for 2,4,4-Trimethyl-2-pentanol-Induced a2m-Globulin Nephropathyin Male Fischer 344 Rats. Fundam. Appl. Toxicol. 25, 124-137.
12. Bull, R. J., Brown, J. M., Meierhenry, E. A., Jorgenson, T. A., Robinson, A., and Stober, J. A. 1986. Enhancement of the Hepatotoxicity of Chloroform in B6C3F1 Mice by Corn Oil: Implications for Chloroform Carcinogenesis. Environ. Health Perspect. 69, 49-58.
13. Clewell, H.J. 1997. Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment. J. Toxicol. Environ. Health 52, 475-515.
14. Clewell, H.J., III and Jarnot, B. M. 1994. Incorporation of Pharmacokinetics in Noncancer Risk Assessment: Example with Chloropentafluorobenzene. Risk Anal 14, 265-276.
15. Clewell, H.J., III, Gentry, P. R., Gearhart J. M., Allen, B. C., and Andersen, M. E. 1995. Considering Pharmacokinetic and Mechanistic Information in Cancer Risk Assessment for Environmental Contaminants: Examples with Vinyl Chloride and Trichloroethylene. Chemosphere 31, 2561-2578.
16. Collins, J.M., Grieshaber, C.K., and Chabner, B.A. 1990. Pharmacologically Guided Phase I Clinical Trials Based upon Preclinical Drug Development. J. Natl. Cancer. Inst. 82, 1321-1326.
17. CRARM (Commission on Risk Assessment and Risk Management). 1997. Risk Assessment and Risk Management in Regulatory Decision-Making.
18. Crawford, M. and Wilson, R. 1996. Low-Dose Linearity: The Rule or the Exception? Hum. Ecol. Risk Assess. 2, 305-330.
19. Crump, K. S., Hoel, D. G., Langley, C. H., and Peto, R. 1976. Fundamental Carcinogenic Processes and Their Implications for Low Dose Risk Assessment. Cancer Res. 36, 2973-2979.
20. Crump, K. 1984. A New Method for Determining Allowable Daily Intakes. Fundam. Appl. Toxicol. 4, 854-871.
21. Crump, K. S. and Crockett, P. W. 1985. Improved Confidence Limits for Low-Dose Carcinogenic Risk Assessment from Animal Data. J. Haz. Mat. 10, 419-431.
22. Crump, K., Clewell, H. J., and Andersen, M. E. 1996. Cancer and Non-cancer Risk Assessment Should Be Harmonized. BELLE Newsletter 5, 2-3.
23. Daston, G. P. 1993. Do Thresholds Exist for Developmental Toxicants? A Review of the Theoretical and Experimental Evidence. In: Issues and Reviews in Teratology, Volume 6. (Kalter, H., ed.). New York, Plenum Press.
24. Dourson, M. L. 1994. Methods for Establishing Oral Reference Doses. Risk Assessment of Essential Elements. (W. Mertz, C. O. Abernathy and S. S. Olin, eds.) Washington, DC, ILSI Press.
25. Dourson, M. L. and Stara, J. F. 1983. Regulatory History and Experimental Support of Uncertainty (Safety) Factors. Reg. Toxicol. Pharmacol. 3, 224-238.
26. D'Souza, R. W., Francis, W. R., Bruce, R. D., and Andersen, M. E. 1987. Physiologically Based Pharmacokinetic Model for Ethylene Dichloride and Its Application in Risk Assessment. In: Drinking Water and Health: Pharmacokinetics in Risk Assessment, Volume 8, pp. 286-301. National Academy Press, Washington, D. C.
27. Ennever, F. K. 1994. Metals. In: Principles and Methods of Toxicology, Third Edition, pp. 417-446. (Hayes, A. W., ed.), New York, Raven Press, Ltd.
28. Freireich, E. J., Gehan, E. A., Rall, D. P., Schmidt, L. H., and Skipper, H. E. 1966. Quantitative Comparison of Toxicity of Anticancer Agents in Mouse, Rat, Hamster, Dog, Monkey and Man. Cancer Chemother. Rep. 50(4), 219-244.
29. Gaylor, D. W. and Razzaghi, M. 1992. Process of Building Biologically Based Dose Response Models for Developmental Defects. Teratology 46, 573-581.
30. Gold, L. S., Slone, T. H., Stern, B. R., Manley, N. B., and Ames, B. N. 1992. Rodent Carcinogens: Setting Priorities. Science 258, 261-265.
31. Hartung, R. and Durkin, P. R. 1986. Ranking the Severity of Toxic Effects: Potential Applications to Risk Assessment. Comments Toxicol., 1, 49-63.
32. Hernandez, O., Rhomberg, L., Hogan, K., Siegel-Scott, C., Lai, D. Grindstaff, G., Henry, M., and Cotruvo, J. A. 1994. Risk Assessment of Formaldehyde. J. Haz. Mat. 39, 161-172.
33. Jarabek, A. M. 1995. Interspecies Extrapolation Based on Mechanistic Determinants of Chemical Disposition. Hum. Risk Assess. 1, 641-662.
34. Kavlock, R. J. and Setzer, R. W. 1996. The Road to Embryologically Based Dose-Response Models. Environ. Health Perspect. 104, Suppl. 1, 107-121.
35. Lehman, A. J. and Fitzhugh, O. G. 1954. 100-Fold Margin of Safety. Assoc Food Drug Off U.S.Q. Bull 18, 33-35.
36. Luecke, R. H., Wosilait, W. D., Pearce, B. A., and Young J.F. 1994. A Physiologically Based Pharmacokinetic Computer Model for Human Pregnancy. Teratology 49, 90-103.
37. Magee, B., Anderson, P., and Burmaster, D. 1996. Absorption Adjustment Factor (AAF) Distributions for Polycyclic Aromatic Hydrocarbons (PAHs). Human Ecol. Risk Assess. 2, 841-873.
38. Monticello, T. M., Swenberg, J. A., Gross, E. A., Leininger, J. R., Kimbell, J. S., Seilkop, W., Starr, T. B., Gibson, J. E., and Morgan, K. T. 1996. Correlation of Regional and Nonlinear Formaldehyde-Induced Nasal Cancer with Proliferating Populations of Cells. Cancer Res. 56, 1012-1022.
39. Moolgavkar, S. H. and Knudson, A. G., Jr. 1981. Mutation and Cancer: A Model for Human Carcinogenesis. J. Natl. Cancer Inst. 66, 1037-1052.
40. NAS/NRC (National Academy of Sciences/National Research Council). 1983. Risk Assessment in the Federal Government: Managing the Process. Washington, D. C., NAS Press.
41. NAS/NRC (National Academy of Sciences/National Research Council). 1986. Drinking Water and Health, Volume 6. (Thomas, R. D., ed.). Washington, D.C., National Academy Press.
42. NAS/NRC. (National Academy of Sciences/National Research Council). 1994. Science and Judgment in Risk Assessment. Washington, D.C., NAS Press.
43. Naumann, B. D. and Weideman, P. A. 1995. Scientific Basis for Uncertainty Factors Used to Establish Occupational Exposure Limits for Pharmaceutical Active Ingredients. Hum. Ecol. Risk Assess. 1, 590-613.
44. O'Flaherty, E. J. 1989. Interspecies Conversion of Kinetically Equivalent Doses. Risk Anal. 9, 587-598.
45. Plowchalk, D.R., Andersen, M.E., and Bogdanffy, M.S. 1997. Physiologically Based Modeling of Vinyl Acetate Uptake, Metabolism, and Intracellular pH changes in the Rat Nasal Cavity. Toxicol. Appl. Pharmacol. 142, 386-400.
46. Portier, C., Tritscher, A., Kohn, M., Sewall, C., Clark, G., Edler, L., Hoel, D., and Lucier, G. 1993. Ligand/Receptor Binding for 2,3,7,8-TCDD: Implications for Risk Assessment. Fundam. Appl. Toxicol 20, 48-56.
47. Reitz, R. H., Mendrala, A. L., Park, C. N., Andersen, M. E., and Guengerich, F. P. 1988. Incorporation of In Vitro Enzyme Data into the Physiologically-Based Pharmacokinetic (PB-PK) Model for Methylene Chloride: Implications for Risk Assessment. Toxicol. Lett. 43, 97-116.
48. Reitz, R. H., Gargas, M. L., Andersen, M. E., Provan, W. M., and Green, T. L. 1996. Predicting Cancer Risk from Vinyl Chloride Exposure with a Physiologically Based Pharmacokinetic Model. Toxicol. Appl. Pharmacol. 137, 253-267.
49. Remvick, A. G. 1991. Safety Factors and the Establishment of ADI. Food Add. Contam. 8, 135-150.
50. Renwick, A.G. 1993. Data-derived safety factors for the evaluation of food additives and environmental contaminants. Food Add. Contam. 10, 275-305.
51. Scheuplein, R. J., Shoaf, S. E., and Brown, R. N. 1990. Role of Pharmacokinetics in Safety Evaluation and Regulatory Considerations. Annu. Rev. Pharmacol. Toxicol. 30, 197-218.
52. Schilter, B., Renwick, A. G., and Huggett, A. C. 1996. Limits for Pesticide Residues in Infant Foods: A Safety-Based Proposal. Regul. Toxicol. Pharmacol. 24, 126-140.
53. Starr, T. B. 1990. Quantitative Cancer Risk Estimation for Formaldehyde. Risk Anal. 10, 85-91.
54. Travis, C.C., and White, R.K. 1988. Interspecific Scaling of Toxicity Data. Risk Anal. 8, 119-125.
55. Travis, C.C. 1990. Tissue Dosimetry for Reactive Metabolites. Risk Anal. 10, 317-321.
56. Travis, C. C., White, R. K., and Ward, R. C. 1990. Interspecies Extrapolation of Pharmacokinetics. J. Them. Biol. 142, 285-304.
57. USEPA. (U.S. Environmental Protection Agency). 1986a. Guidelines for Carcinogen Risk Assessment. Fed. Regist. 51, 33992.
58. USEPA (U.S. Environmental Protection Agency). 1986b. Guidelines for Health Risk Assessment of Chemical Mixtures. Fed. Regist. 51, 34014.
59. USEPA (U.S. Environmental Protection Agency). 1987. Update to the Health Assessment Document and Addendum for Dichloromethane (Methylene Chloride) Pharmacokinetics, Mechanism of Action, and Epidemiology. External Review Draft, EPA/600/8-87/030A, 1987.
60. USEPA (U.S. Environmental Protection Agency). 1989a. Exposure Factors Handbook. Office of Health and Environmental Assessment, Washington, D. C., USEPA/600/ 8-89/043.
61. USEPA (U.S. Environmental Protection Agency). 1989b. Risk Assessment Guidance for Superfund: Human Health Evaluation Manual (Part A). Washington, DC, USEPA/ 540/1-89/002.
62. 2u-Globulin: Association with Chemically Induced Renal Toxicity and Neoplasia in the Male Rat. Risk Assessment Forum, Washington, D.C., USEPA/625/3-91/019F.
63. USEPA (U.S. Environmental Protection Agency). 1991b. Formaldehyde Risk Assessment Update - Final Draft. Office of Toxic Substances, U.S. Environmental Protection Agency, Washington, D.C.
64. USEPA (U.S. Environmental Protection Agency). 1991c. Guidelines for Developmental Toxicity Risk Assessment. Fed. Regist. 56(234), 63798-63826.
65. USEPA (U.S. Environmental Protection Agency). 1992. USEPA Request For Comments on Draft Report on Cross-Species Scaling Factor for Cancer Risk Assessment. Fed. Regist. 57, 24152.
66. USEPA (U.S. Environmental Protection Agency). 1994. Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry. Office of Research and Development, Washington, D. C., USEPA/600/90/066F.
67. USEPA (U.S. Environmental Protection Agency). 1995. Guidelines for Neurotoxicity Risk Assessment. Fed. Regist. 60, 52032-52056.
68. USEPA (U.S. Environmental Protection Agency). 1996a. Guidelines for Reproductive Toxicity Risk Assessment. Office of Research and Development, Washington, D. C., USEPA/630/R-96/009.
69. USEPA (U.S. Environmental Protection Agency). 1996b. Integrated Risk Information System (IRIS), U.S. Environmental Protection Agency.
70. USEPA (U.S. Environmental Protection Agency). 1996c. Proposed Guidelines for Carcinogen Risk Assessment. Office of Research and Development, Washington, D. C., USEPA 600-P-92-/P-92/003C.
71. Weinberg, R. A. 1996. How Cancer Arises. Scientific American, September, 62-70.
72. Wiesner, T. F., Berk, B. C., and Nerem, R. M. 1996. A Mathematical Model of Cytosolic Calcium Dynamics in Human Umbilical Vein Endothelial Cells. Am. J. Physiol. 27(Cell. Physiol. 39) C1556-C1569.
73. Williams, G. M. and Weisburger, J. H. 1991. Chemical Carcinogenesis. In: Casarett and Doull's Toxicology: The Basic Science of Poisons, fourth edition, pp. 127-200. (Amdur, M. O., Doull, J., and Claassen, C. D., eds.). New York., McGraw-Hill, Inc.